John M Slopis
Overview
Explore the profile of John M Slopis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
832
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tomczak K, Patel M, Bhalla A, Peterson C, Landers S, Callahan S, et al.
Mol Carcinog
. 2024 Nov;
64(1):44-56.
PMID: 39600120
Malignant peripheral nerve sheath tumor (MPNST) development is characterized by an altered DNA methylation landscape, which presents a promising area for developing MPNST-specific biomarkers for screening patients with NF1. Genome-wide...
2.
He J, Connors J, Meador A, Xu S, Meador H, Jiang H, et al.
Neuro Oncol
. 2024 Nov;
27(3):625-643.
PMID: 39535217
Significant gaps remain in our understanding of immunotherapy-related neurotoxicity in pediatric patients, largely because much of our knowledge comes from studies in adults. Accurately identifying the adverse effects of immunotherapy...
3.
Dasgupta P, McCutcheon I, Slopis J
Can J Neurol Sci
. 2024 Oct;
:1.
PMID: 39358987
No abstract available.
4.
Lam K, Kamiya-Matsuoka C, Slopis J, McCutcheon I, Majd N
JCO Precis Oncol
. 2024 Feb;
8:e2300442.
PMID: 38394467
Purpose: The purpose of this article was to provide an overview of syndromic gliomas. Design: The authors conducted a nonsystematic literature review. Results: Cancer predisposition syndromes (CPSs) are genetic conditions...
5.
North R, Snyder R, Slopis J, McCutcheon I
J Neurosurg Case Lessons
. 2022 Jul;
1(26):CASE21176.
PMID: 35854908
Background: Neurofibromatosis syndromes such as neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis often result in painful symptoms related to tumor burden. Observations: Painful symptoms classically associated with common points...
6.
Bhalla A, Landers S, Singh A, Landry J, Yeagley M, Myerson G, et al.
Lab Invest
. 2022 Mar;
102(6):658-666.
PMID: 35228656
Undifferentiated pleomorphic sarcoma (UPS) and malignant peripheral nerve sheath tumor (MPNST) are aggressive soft tissue sarcomas that do not respond well to current treatment modalities. The limited availability of UPS...
7.
Kochat V, Raman A, Landers S, Tang M, Schulz J, Terranova C, et al.
Acta Neuropathol
. 2021 Jul;
142(3):565-590.
PMID: 34283254
Malignant peripheral nerve sheath tumors (MPNSTs) are soft tissue sarcomas that frequently harbor genetic alterations in polycomb repressor complex 2 (PRC2) components-SUZ12 and EED. Here, we show that PRC2 loss...
8.
Brown B, Tambaro F, Kohorst M, Chi L, Mahadeo K, Tewari P, et al.
Front Oncol
. 2021 Mar;
11:634445.
PMID: 33763368
The Cornell Assessment for Pediatric Delirium (CAPD) was first proposed by the Pediatric Acute Lung Injury and Sepsis Investigators Network-Stem Cell Transplantation and Cancer Immunotherapy Subgroup and MD Anderson CARTOX...
9.
Landry J, Schertz K, Chiang Y, Bhalla A, Yi M, Keung E, et al.
JAMA Netw Open
. 2021 Mar;
4(3):e210945.
PMID: 33734413
Importance: Neurofibromatosis type 1 (NF1) is a complex genetic disorder that is associated with not only neurofibromas, but also an increased susceptibility to other neoplasms. Objective: To evaluate the prevalence...
10.
Cabrera T, Wang W, Yedururi S, Slopis J, Steiner R, Rytting M, et al.
J Pediatr Hematol Oncol
. 2020 May;
43(4):e535-e538.
PMID: 32366782
Neurofibromatosis Type 1 (NF1) is a genetic disorder with an incidence of 1 in 2600 to 3000 individuals. It is a clinical diagnosis characterized by café-au-lait macules, neurofibromas, and axillary...